Biggest News Aggregation in the World
📰 Otl 200 News

Otl 200 News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Otl 200. Real-time updates on events, politics, business and more.

Kyowa acquiring gene therapy firm Orchard for up to $478M

Japanese specialty global pharma Kyowa Kirin Co. Ltd. has agreed to buy out Orchard Therapeutics plc in a $387.4 million cash takeover that could jump $90 million to reach $477.6 million, contingent on the pending U.S. FDA approval of its EU-approved gene therapy, Libmeldy (atidarsagene autotemcel).
Kyowa Kirin Co Kyowa Kirin Orchard Therapeutics Kyowa Kirin Co Ltd Orchard Therapeutics Plc Otl 200

Kyowa acquiring gene therapy firm Orchard for up to $478M

Japanese specialty global pharma Kyowa Kirin Co. Ltd. has agreed to buy out Orchard Therapeutics plc in a $387.4 million cash takeover that could jump $90 million to reach $477.6 million, contingent on the pending U.S. FDA approval of its EU-approved gene therapy, Libmeldy (atidarsagene autotemcel).
Kyowa Kirin Co Kyowa Kirin Orchard Therapeutics Kyowa Kirin Co Ltd Orchard Therapeutics Plc Otl 200

Orchard Therapeutics Says FDA Accepts BLA For OTL-200 In Metachromatic Leukodystrophy

Orchard Therapeutics (ORTX), a global gene therapy leader, announced Monday that the U.S. Food and Drug Administration (FDA) has accepted the filing of its Biologics License Application (BLA) for OTL-200 in metachromatic leukodystrophy (MLD) under Priority Review.
Drug Administration Orchard Therapeutics Biologics License Application Prescription Drug User Fee Act Rare Pediatric Disease Regenerative Medicine Advanced Therapy

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science